Literature DB >> 10886525

Inherited dystrophic epidermolysis bullosa in inbred dogs: A spontaneous animal model for somatic gene therapy.

X Palazzi, T Marchal, L Chabanne, A Spadafora, J P Magnol, G Meneguzzi.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10886525     DOI： 10.1046/j.1523-1747.2000.00031-5.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  6 in total

Review 1.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

Review 2.  Cell therapy in dermatology.

Authors:  Gabriela Petrof; Alya Abdul-Wahab; John A McGrath
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

3.  A COL7A1 mutation causes dystrophic epidermolysis bullosa in Rotes Höhenvieh cattle.

Authors:  Annie Menoud; Monika Welle; Jens Tetens; Peter Lichtner; Cord Drögemüller
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

4.  Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in Central Asian Shepherd dogs.

Authors:  Julia Niskanen; Kati Dillard; Meharji Arumilli; Elina Salmela; Marjukka Anttila; Hannes Lohi; Marjo K Hytönen
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

5.  A COL7A1 Variant in a Litter of Neonatal Basset Hounds with Dystrophic Epidermolysis Bullosa.

Authors:  Teresa Maria Garcia; Sarah Kiener; Vidhya Jagannathan; Duncan S Russell; Tosso Leeb
Journal:  Genes (Basel)       Date:  2020-12-04       Impact factor: 4.096

6.  Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.

Authors:  Alexander Nyström; Jens Buttgereit; Michael Bader; Tatiana Shmidt; Cemil Ozcelik; Ingrid Hausser; Leena Bruckner-Tuderman; Johannes S Kern
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.